| Primary |
| Schizophrenia |
55.8% |
| Schizoaffective Disorder |
9.1% |
| Schizophrenia, Paranoid Type |
8.5% |
| Psychotic Disorder |
7.1% |
| Depression |
3.0% |
| Bipolar Disorder |
2.6% |
| Hypertension |
1.5% |
| Anxiety |
1.5% |
| Product Used For Unknown Indication |
1.4% |
| Constipation |
1.2% |
| Parkinson's Disease |
1.1% |
| Diabetes Mellitus |
1.0% |
| Salivary Hypersecretion |
1.0% |
| Insomnia |
0.9% |
| Affective Disorder |
0.8% |
| Agitation |
0.8% |
| Dementia |
0.7% |
| Hypothyroidism |
0.7% |
| Asthma |
0.6% |
| Epilepsy |
0.6% |
|
| Granulocytopenia |
24.1% |
| Death |
23.8% |
| Leukopenia |
10.9% |
| White Blood Cell Count Decreased |
3.8% |
| Pneumonia |
3.7% |
| Treatment Noncompliance |
3.2% |
| Myocardial Infarction |
3.1% |
| White Blood Cell Count Increased |
3.0% |
| Psychotic Disorder |
2.6% |
| Unevaluable Event |
2.6% |
| Vomiting |
2.4% |
| Pyrexia |
2.3% |
| Urinary Tract Infection |
2.2% |
| Neutrophil Count Decreased |
2.0% |
| Neutropenia |
1.9% |
| Pre-existing Disease |
1.9% |
| Weight Increased |
1.8% |
| Lung Neoplasm Malignant |
1.6% |
| Neoplasm Malignant |
1.6% |
| Tachycardia |
1.5% |
|
| Secondary |
| Schizophrenia |
29.4% |
| Product Used For Unknown Indication |
24.5% |
| Schizophrenia, Paranoid Type |
9.0% |
| Psychotic Disorder |
5.7% |
| Drug Use For Unknown Indication |
5.6% |
| Schizoaffective Disorder |
4.2% |
| Depression |
3.3% |
| Hypertension |
2.9% |
| Bipolar Disorder |
2.4% |
| Constipation |
1.9% |
| Drug Abuse |
1.6% |
| Anxiety |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.4% |
| Hypothyroidism |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Ill-defined Disorder |
1.0% |
| Non-hodgkin's Lymphoma Unspecified Histology Aggressive |
1.0% |
| Agitation |
0.8% |
| Parkinson's Disease |
0.8% |
| Urinary Tract Infection |
0.8% |
|
| Granulocytopenia |
19.6% |
| Leukopenia |
13.5% |
| Death |
7.6% |
| White Blood Cell Count Decreased |
6.5% |
| Neutropenia |
5.5% |
| Tremor |
5.1% |
| White Blood Cell Count Increased |
5.0% |
| Weight Increased |
4.2% |
| Psychotic Disorder |
3.8% |
| Vomiting |
3.2% |
| Pyrexia |
3.0% |
| Somnolence |
2.9% |
| Overdose |
2.9% |
| Suicide Attempt |
2.9% |
| Tachycardia |
2.6% |
| Thrombocytopenia |
2.5% |
| Drug Interaction |
2.4% |
| Neutrophil Count Decreased |
2.4% |
| Pneumonia |
2.4% |
| Agranulocytosis |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.4% |
| Schizophrenia |
16.3% |
| Drug Use For Unknown Indication |
10.8% |
| Depression |
6.8% |
| Bipolar Disorder |
4.1% |
| Schizophrenia, Paranoid Type |
3.9% |
| Parkinson's Disease |
3.9% |
| Psychotic Disorder |
3.9% |
| Anxiety |
3.2% |
| Hypertension |
1.9% |
| Schizoaffective Disorder |
1.9% |
| Diabetes Mellitus |
1.5% |
| Pain |
1.5% |
| Cardiac Disorder |
1.2% |
| Insomnia |
1.2% |
| Sleep Disorder |
1.2% |
| Epilepsy |
1.1% |
| Smoking Cessation Therapy |
1.1% |
| Salivary Hypersecretion |
1.1% |
| Back Pain |
1.0% |
|
| Overdose |
11.4% |
| Weight Increased |
9.3% |
| Vomiting |
8.8% |
| White Blood Cell Count Decreased |
7.9% |
| Neuroleptic Malignant Syndrome |
5.6% |
| White Blood Cell Count Increased |
4.9% |
| Somnolence |
4.6% |
| Type 2 Diabetes Mellitus |
4.6% |
| Death |
4.4% |
| Neutropenia |
4.4% |
| Psychotic Disorder |
4.4% |
| Tremor |
4.4% |
| Granulocytopenia |
3.7% |
| Schizophrenia |
3.5% |
| Drug Interaction |
3.2% |
| Treatment Noncompliance |
3.2% |
| Tachycardia |
3.0% |
| Weight Decreased |
3.0% |
| Hyponatraemia |
2.8% |
| Paranoia |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
28.7% |
| Schizophrenia |
16.7% |
| Drug Use For Unknown Indication |
11.0% |
| Schizophrenia, Paranoid Type |
10.1% |
| Obsessive-compulsive Disorder |
3.4% |
| Constipation |
3.3% |
| Salivary Hypersecretion |
3.0% |
| Psychotic Disorder |
2.9% |
| Rheumatoid Arthritis |
2.5% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Bipolar Disorder |
2.1% |
| Hepatitis C |
1.9% |
| Non-hodgkin's Lymphoma Unspecified Histology Aggressive |
1.9% |
| Schizoaffective Disorder |
1.8% |
| Anxiety |
1.6% |
| Insomnia |
1.6% |
| Schizophrenia, Catatonic Type |
1.6% |
| Aggression |
1.5% |
| Agitation |
1.1% |
| Depression |
1.1% |
|
| Drug Interaction |
20.3% |
| Drug Level Increased |
6.5% |
| Grand Mal Convulsion |
6.5% |
| Neutropenia |
5.5% |
| Psychotic Disorder |
5.1% |
| Toxicity To Various Agents |
5.1% |
| White Blood Cell Count Decreased |
5.1% |
| Cough |
4.6% |
| Decreased Appetite |
4.6% |
| Asterixis |
4.1% |
| Diarrhoea |
4.1% |
| Restlessness |
4.1% |
| Dystonia |
3.7% |
| Lymphocyte Count Decreased |
3.7% |
| Urinary Tract Infection |
3.7% |
| Repetitive Speech |
3.2% |
| Rhabdomyolysis |
2.8% |
| Somnolence |
2.8% |
| Antipsychotic Drug Level Increased |
2.3% |
| Depressed Mood |
2.3% |
|
